Biotransformation of selected secondary metabolites by alternaria species and the pharmaceutical, food and agricultural application of biotransformation products
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores
Its a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
We evaluate patients for tirzepatide prescriptions based on individual health history and eligibility criteria
Cell Mol Neurobiol 31:429436 Mescka CP, Wayhs CA, Vanzin CS, Biancini GB, Guerreiro G, Manfredini V, Souza C, Wajner M, Dutra-Filho CS, Vargas CR (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect